Janssen Submits Crohn’s Disease Drug STELARA for Approval in the United States and European Union
Crohn's Disease, News
Janssen Biotech, Inc. and Janssen-Cilag International NV, both part of the Janssen Pharmaceutical Companies of Johnson & Johnson, recently announced the submission of the company’s product STELARA® (ustekinumab), developed as ... Read more